Cinepazide

Cinepazide
Clinical data
ATC code	C04AX27 (WHO) ;
Identifiers
	IUPAC name (2E)-1-{4-[2-Oxo-2-(1-pyrrolidinyl)ethyl]-1-piperazinyl}-3-(3,4,5-trimethoxyphenyl)-2-propen-1-one;
CAS Number	23887-46-9;
PubChem CID	5282459;
ChemSpider	4445611 ;
UNII	67Y4P5C84X;
ChEMBL	ChEMBL1874750 ;
CompTox Dashboard (EPA)	DTXSID5048261 ;
ECHA InfoCard	100.041.739
Chemical and physical data
Formula	C22H31N3O5
Molar mass	417.506 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(N1CCCC1)CN3CCN(C(=O)\C=C\c2cc(OC)c(OC)c(OC)c2)CC3;
	InChI InChI=1S/C22H31N3O5/c1-28-18-14-17(15-19(29-2)22(18)30-3)6-7-20(26)25-12-10-23(11-13-25)16-21(27)24-8-4-5-9-24/h6-7,14-15H,4-5,8-13,16H2,1-3H3/b7-6+ ; Key:RCUDFXMNPQNBDU-VOTSOKGWSA-N ;
	(what is this?) (verify)

Cinepazide or cinepazide maleate (Kelinao or Anjieli in China) is a vasodilator used in China for the treatment of cardiovascular and cerebrovascular diseases, and peripheral vascular diseases. It appears to work by potentiating A2 adenosine receptors.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.